Literature DB >> 32857949

Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer.

Siddhartha Devarakonda1, Ramaswamy Govindan1, Daniel Morgensztern2.   

Abstract

In a recent Nature article, Middleton et al. report the National Lung Matrix trial results where patients with previously treated non-small cell lung cancer (NSCLC) are assigned to personalized therapy based on the results of a 28-gene next-generation sequencing panel test.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID： 32857949     DOI： 10.1016/j.ccell.2020.07.011

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  3 in total

1.  CircMMP11 overexpression predicts the poor survival of non-small cell lung cancer and downregulates miR-143 through methylation to suppress cell proliferation.

Authors:  Juan Chen; Jiang Gong
Journal:  J Cardiothorac Surg       Date:  2021-11-08       Impact factor: 1.637

2.  LncRNA LINC00520 aggravates cell proliferation and migration in lung adenocarcinoma via a positive feedback loop.

Authors:  Wen Huang; Xinxing Wang; Fubing Wu; Fanggui Xu
Journal:  BMC Pulm Med       Date:  2021-09-08       Impact factor: 3.317

3.  Identification of Prognostic Markers of N6-Methylandenosine-Related Noncoding RNAs in Non-Small-Cell Lung Cancer.

Authors:  Zexin Zhang; Jing Li; Ke Lu; Wenfeng Wu; Ziyi Huang; Chi Zhang; Wei Guo; Jiayin Li; Lizhu Lin
Journal:  J Oncol       Date:  2022-04-01       Impact factor: 4.375
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.